fclitloan

The Contract Manufacturing Market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world.

Roots Analysis is pleased to announce the publication of its recent study, titled, “.”

The report features an extensive study of the current malaoji.orgrket landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features:

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Key Geographical Regions

Type of Product

Type of Drug Product

Scale of Operation

Company Size

Key players covered in the report

For more information, please click on the following link:

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

About Roots Analysis

is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com